Acquisition leverage TECHLAB is now part of SSI Diagnostica Group, unlocking access to a broader global IVD portfolio and cross-sell opportunities across infectious disease diagnostics, microbiology, and related testing solutions.

Global reach As a brand under a multinational group with operations in Denmark, the United States, and China and sales in over 130 countries, there is potential to expand TECHLAB’s tests into new regional markets via SSI Diagnostica's distribution network.

Brand synergy Leverage SSI Diagnostica’s four disease focus areas—Gastric, Respiratory, Bloodborne, and general microbiology—to position TECHLAB’s rapid infectious disease tests as complementary diagnostics within integrated panels.

Product-market fit With a revenue range indicative of mid-market presence and a leadership role in rapid GI and enteric diagnostics, there are upsell opportunities to hospitals and labs seeking rapid, accurate tests within SSI’s infectious disease portfolio.

Strategic partnerships Recent leadership changes and continued recognition in partner ecosystems (e.g., Fisher Healthcare awards) suggest openings for co-marketing, joint demonstrations, and bundled solutions with SSI Diagnostica’s partners and customers.